Quobly's €115M Series A: France Bets on Silicon-Based Quantum
French quantum startup Quobly raised €115M Series A in June 2026 to industrialize silicon-based quantum processors compatible with existing semiconductor fabs.
Europe's venture capital market is maturing rapidly, with growing LP appetite for deep tech, defense, fintech, and sovereign AI capabilities. Our European VC coverage tracks fund formation, mega-rounds, and the policy and capital dynamics shaping the continent's startup ecosystem.
Browse European venture capital articles for regional funding insight.
French quantum startup Quobly raised €115M Series A in June 2026 to industrialize silicon-based quantum processors compatible with existing semiconductor fabs.
Stockholm AI startup Endra raised $50M Series A in June 2026 to automate design work for mechanical, electrical, and plumbing (MEP) consultants.
UK biotech IMU Biosciences extended its oversubscribed Series A past $53M in June 2026 to map and decode the human immune system for drug discovery.
Barcelona biopharma Ona Therapeutics closed an oversubscribed $86.6M Series B in June 2026 to advance first-in-class antibody-drug conjugates for resistant cancers.
UK healthcare-tech company Semble raised a £30M Series C led by Revaia in June 2026, scaling its practice-management platform for clinicians.
Edinburgh legal-AI startup Wordsmith raised a $70M Series B in June 2026, backed by Highland Europe and Index Ventures, reaching $100M in total funding.